New FDA xenotransplantation documents: a proposed rule and a draft guidance

被引：0
|
作者：
Bloom, ET [1 ]
机构：
[1] US FDA, CBER, DCGT, LCI, Bethesda, MD 20892 USA
来源：
XENOTRANSPLANTATION | 2001年 / 8卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：153 / 154
页数：2
相关论文
共 50 条
  • [1] FDA stability draft guidance documents
    不详
    [J]. LARGE ANIMAL PRACTICE, 1998, 19 (06): : 12 - 12
  • [2] New FDA guidance documents
    Bradshaw, Sheldon T.
    [J]. FOOD AND DRUG LAW JOURNAL, 2007, 62 (02) : 429 - 431
  • [3] New FDA Draft Guidance on Immunogenicity
    Ashwin Parenky
    Heather Myler
    Lakshmi Amaravadi
    Karoline Bechtold-Peters
    Amy Rosenberg
    Susan Kirshner
    Valerie Quarmby
    [J]. The AAPS Journal, 2014, 16 : 499 - 503
  • [4] New FDA Draft Guidance on Immunogenicity
    Parenky, Ashwin
    Myler, Heather
    Amaravadi, Lakshmi
    Bechtold-Peters, Karoline
    Rosenberg, Amy
    Kirshner, Susan
    Quarmby, Valerie
    [J]. AAPS JOURNAL, 2014, 16 (03): : 499 - 503
  • [5] FDA Releases New Draft Guidance on Compounded Drugs
    不详
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (02) : 8N - 8N
  • [6] FDA draft guidance on compounding and repackaging
    [J]. Reactions Weekly, 2015, 1540 (1) : 2 - 2
  • [7] FDA's draft guidance on pharmacogenomics
    Hellman, K
    Smith, D
    [J]. GENETIC ENGINEERING NEWS, 2005, 25 (04): : 18 - +
  • [8] FDA Draft Guidance on the Naming of Biosimilars
    Fernandez-Lopez, Sara
    [J]. BIODRUGS, 2015, 29 (05) : 323 - 325
  • [9] FDA Draft Guidance on the Naming of Biosimilars
    Sara Fernandez-Lopez
    [J]. BioDrugs, 2015, 29 : 323 - 325
  • [10] FDA issues nanotech draft guidance
    Nachay, Karen
    [J]. FOOD TECHNOLOGY, 2012, 66 (06) : 16 - 16
12345